How many milliliters of Zepbound (tirzepatide) are needed for a one‑month supply with weekly dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Zepbound Volume for One-Month Supply

For a one-month supply of Zepbound (tirzepatide) with weekly dosing, you need 2 mL total (0.5 mL per injection × 4 weekly doses).

Dosing Details

Zepbound is administered as a once-weekly subcutaneous injection 1, 2, 3. Each single-use pen delivers 0.5 mL per injection, regardless of the dose strength (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) 1, 3.

Monthly Volume Calculation:

  • 0.5 mL per week × 4 weeks = 2 mL per month
  • This equals 4 single-use pens per month (one pen per week)

Dose Escalation Schedule

Tirzepatide follows a structured dose escalation:

  • Weeks 1-4: 2.5 mg (0.5 mL) weekly
  • Weeks 5-8: 5 mg (0.5 mL) weekly
  • Weeks 9-12: 7.5 mg (0.5 mL) weekly
  • Weeks 13-16: 10 mg (0.5 mL) weekly
  • Weeks 17-20: 12.5 mg (0.5 mL) weekly
  • Week 21+: 15 mg (0.5 mL) weekly (maximum tolerated dose)

The maintenance dose is typically 10 mg or 15 mg weekly 4, 5, 6, 7, 8.

Key Clinical Points

Volume remains constant: The 0.5 mL injection volume stays the same across all dose strengths—only the concentration changes 1, 3. This is critical for patient education and prescription accuracy.

Prescription specifications: When prescribing for one month, specify "4 single-use pens" of the appropriate dose strength, which provides the 2 mL total volume needed for weekly administration.

The dose escalation period typically spans 20 weeks before reaching the maximum tolerated dose, so monthly prescriptions will involve different dose strengths during titration 8, 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.